RNA ANTAGONIST COMPOUNDS FOR THE MODULATION OF BETA-CATENIN

• 收藏
• 分享

专利权人:

Santaris Pharma A/S

发明人:

WORM, Jesper

申请号：

AU2014265070

公开号：

AU2014265070A1

申请日:

2014.11.20

申请国别(地区):

AU

年份:

2014

代理人:

摘要：

#$%^&*AU2014265070A120141211.pdf#####Abstract The invention relates to oligomeric compounds (oligomers), which target beta-catenin mRNA in a cell, leading to 5 reduced expression of beta-catenin. Reduction of betacatenin expression is beneficial for a range of medical disorders, such as hyperproliferative diseases, including cancer. The invention provides therapeutic compositions comprising oligomers and methods for modulating the io expression of beta-catenin using said oligomers, including methods of treatment. 59597301 (GHMatters) P82346.AU.1 PETERB 17/11/14

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/